背景:口腔鳞状细胞癌(oral squamous cell carcinoma OSCC)是口腔中最为常见的恶性肿瘤,占口腔颌面部恶性肿瘤的80%以上,研…www.showxiu.com|基于2个网页 2. 口腔鳞癌 【摘要】:背景与目的: 口腔鳞癌(Oral squamous cell carcinoma OSCC)是最常见的头颈部肿瘤之一,化疗仍然是口腔鳞癌尤其 …cdmd.cnki.com.cn|基于...
背景:口腔鳞状细胞癌(oral squamous cell carcinoma OSCC)是口腔中最为常见的恶性肿瘤,占口腔颌面部恶性肿瘤的80%以上,研…www.showxiu.com|基于2个网页 2. 口腔鳞癌 【摘要】:背景与目的: 口腔鳞癌(Oral squamous cell carcinoma OSCC)是最常见的头颈部肿瘤之一,化疗仍然是口腔鳞癌尤其 …cdmd.cnki.com.cn|基于...
1. Study on the expression of p53、 p16 protein and PCNA in oral precancerous lesion and oral squamous cell carcinoma; 口腔粘膜癌前病变及口腔鳞状上皮细胞癌p53、p16蛋白和PCNA的表达2. Objective To explore the expression of P 16 protein and its significance during the development and ...
Squamous cell carcinoma is managed by surgery, radiation, and chemotherapy singularly or in combination; but regardless of the treatment modality, the five-year survival rate is poor at about 50%. This can be attributed to the fact that about two-thirds of persons with oral squamous cell ...
1.Objective To study the relationship between expression of Survivin and PTEN in carcinogenesis and development of oral squamous cell carcinoma(OSCC).目的探讨口腔鳞状细胞癌发生发展过程中Survivin和PTEN蛋白表达及相关性。 2.Objectives: Oral squamous cell carcinoma(OSCC) is the most common malignant tumor...
Objectives: Oral squamous cell carcinoma(OSCC) is the most common malignant tumor of oral cavity. 目的:口腔鳞状细胞癌是口腔颌面部最常见的恶性肿瘤,目前其治疗仍以手术、放疗和化疗为主,因此有必要探索新的治疗方法。 更多例句>> 5) Oral squamous cell carcinoma(OSCC) 口腔鳞状细胞癌(OSCC)6...
Nimotuzumab plus concurrent chemoradiotherapy for locally advanced cervical squamous cell carcinoma: The randomized, phase 3 CC3 study. 尼妥珠单抗+同步放化疗治疗局部晚期宫颈鳞状细胞癌:随机3期CC3研究 讲者:王俊杰教授 北京大学第...
2.Objective To investigate differential protein expressions between oral squamous carcinoma cell line KB and multidrug resistance cell line KBV200 in vitro.目的探讨人口腔鳞癌体外培养亲本细胞株KB与耐药细胞株KBV200的蛋白质表达差异。 4)oral tongue squamous cell carcinoma口腔舌鳞癌 ...
Role of elective neck dissection in cT2N0 maxillary sinus squamous cell carcinoma Jingjing Wang ,Qigen Fang &Ruihua Luo Article 18 June 2024|Open Access PAK4 inhibition augments anti-tumour effect by immunomodulation in oral squamous cell carcinoma ...
www.nature.com/scientificreports OPEN received: 31 May 2016 accepted: 10 November 2016 Published: 23 December 2016 The overexpressed functional transient receptor potential channel TRPM2 in oral squamous cell carcinoma Ling-Yan Zhao1,*, Wan-Lin Xu1,2,*, Zeng-Qi Xu1,*, Cui Qi3,...